q32026financialsupplemen

UNIVERSAL TECHNICAL INSTITUTE, INC. Q3 FY2026 FINANCIAL SUPPLEMENT

This presentation contains forward-looking statements within the meaning of the safe harbor from civil liability provided for such statements by the Private Securities Litigation Reform Act of 1995 (set forth in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). Forward-looking statements may contain words such as "goal," "target," "future," "estimate," "expect," "anticipate," "intend," "plan," "believe," "seek," "project," "may," "should," "will," the negative form of these expressions or similar expressions. These statements are based on our management’s current beliefs, expectations and assumptions about future events, conditions and results and on information currently available to us. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, achievements or events and circumstances reflected in the forward-looking statements will occur. Discussions containing these forward-looking statements may be found, among other places, in the sections entitled “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” incorporated by reference from our most recent Annual Report on Form 10-K, in our subsequent Quarterly Reports on Form 10-Q and certain of our Current Reports on Form 8-K, as well as any amendments thereto, filed with the Securities and Exchange Commission (the “SEC”). In addition, statements that refer to projections of earnings, revenue, costs or other financial items in future periods; anticipated growth and trends in our business or key markets; cost synergies, growth opportunities and other potential financial and operating benefits; future growth and revenues; future economic conditions and performance; anticipated performance of curriculum; plans, objectives and strategies for future operations; and other characterizations of future events or circumstances, and all other statements that are not statements of historical fact are forward-looking statements. Such statements are based on currently available operating, financial and competitive information and are subject to various risks, uncertainties and assumptions that could cause actual results to differ materially from those anticipated or implied in our forward-looking statements due to a number of factors, including, but not limited to, those set forth under the section entitled “Risk Factors” in our filings with the SEC. Important factors that could affect our actual results include, among other things, failure of our schools to comply with the extensive regulatory requirements for school operations; our failure to maintain eligibility for or our ability to process federal student financial assistance funds; the effect of current and future Title IV Program regulations arising out of negotiated rulemakings, including any potential reductions in funding or restrictions on the use of funds received through Title IV Programs; the effect of future legislative or regulatory initiatives related to veterans’ benefit programs; continued Congressional examination of the for-profit education sector; regulatory investigations of, or actions commenced against, us or other companies in our industry; changes in the state regulatory environment or budgetary constraints; our failure to execute on our growth and diversification strategy, including effectively identifying, establishing and operating additional schools, programs or campuses; our failure to realize the expected benefits of our acquisitions, or our failure to successfully integrate our acquisitions; our failure to improve underutilized capacity at certain of our campuses; enrollment declines or challenges in our students’ ability to find employment as a result of macroeconomic conditions; our failure to maintain and expand existing industry relationships and develop new industry relationships; our ability to update and expand the content of existing programs and develop and integrate new programs in a timely and cost-effective manner while maintaining positive student outcomes; a loss of our senior management or other key employees; failure to comply with the restrictive covenants and our ability to pay the amounts when due under our credit agreements; and other risks that are described from time to time in our public filings. Given these risks, uncertainties and other factors, many of which are beyond our control, you should not place undue reliance on these forward-looking statements. Neither we nor any other person makes any representation as to the accuracy or completeness of these forward-looking statements and, except as required by law, we assume no obligation to update these forward-looking statements publicly, or to revise any forward-looking statements, even if new information becomes available in the future. This presentation also contains estimates and other statistical data made by independent parties, and by us, relating to market size and growth and other data about our industry and our business. This data involves several assumptions and limitations, and you are cautioned not to give undue weight to such estimates. In addition, projections, assumptions and estimates of our future performance and the future performance of the markets in which we operate are necessarily subject to a high degree of uncertainty and risk. Forward-Looking Statements 2

Consolidated Q3 2026 Highlights 3 Q3 2026 Revenue $218.9 million Net Income $2.3 million Adjusted EBITDA $18.2 million Diluted Earnings Per Share $0.04 Note: See Company Press Release and Investor Presentation dated August 5, 2026 for more details on guidance, including non-GAAP reconciliations. Revenue increased 7.2% to $218.9 million. Concorde contributed $80.9 million (11.1% YoY growth), while the UTI division contributed $138.0 million (5.0% YoY growth). Total Full-Time Active Students grew 5.8% year-over-year to 25,131 Net Income was $2.3 million or $0.04 per diluted share Baseline adjusted EBITDA was $27.2 million. Including $9.0 million in growth investments, our reported adjusted EBITDA was $18.2 million. Total available liquidity of $180.5 million, including $40.1 million of short-term investments and $10.4 million of remaining capacity on our revolving credit facility— ample reserves for any potential business needs or new opportunities that may arise. The Company remains well-positioned and confident in delivering its 5-year strategic targets of a 10% Revenue CAGR and Adjusted EBITDA approaching $220M by FY2029.

4 1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18. 3 Mos. 6/30/26 3 Mos. 6/30/25 YoY Change 9 Mos. 6/30/26 9 Mos. 6/30/25 YoY Change Revenues $218.9 $204.3 7.2% $661.2 $613.2 7.8% Operating expenses $215.7 $190.1 13.4% $641.9 $554.7 15.7% Educational services and facilities $118.3 $105.6 12.0% $346.2 $308.2 12.3% Selling, general and administrative $97.3 $84.5 15.1% $295.7 $246.5 20.0% Income from operations $3.2 $14.2 (77.1)% $19.3 $58.5 (67.0)% Total other (expense) income, net $(0.1) $0.2 (173.0)% $0.4 $0.2 82.3% Income tax expense $(0.8) $(3.7) (77.8)% $(4.2) $(14.5) (71.3)% Net income $2.3 $10.7 (78.6)% $15.5 $44.3 (64.9)% Adjusted EBITDA(1) $18.2 $25.3 (27.8)% $59.5 $89.7 (33.6)% Operating cash flow $10.3 $18.1 (42.8)% $17.4 $40.2 (56.7)% Adjusted free cash flow(1) $(21.4) $7.0 (408.0)% $(65.6) $15.0 (538.5)% Purchase of property and equipment $28.2 $11.2 152.0% $80.9 $25.5 217.3% Capitalized costs for intangible assets $3.2 $— —% $4.5 $— —% Consolidated Q3 2026 Summary Results ($ in millions)

5 Consolidated Statements of Operations Trend ($ in thousands, except EPS) 3 Mos. 6/30/26 3 Mos. 3/31/26 3 Mos. 12/31/25 12 Mos. 9/30/25 3 Mos. 9/30/25 3 Mos. 6/30/25 3 Mos. 3/31/25 3 Mos. 9/30/24 12 Mos. 9/30/24 Revenues $ 218,907 $ 221,402 $ 220,844 $ 835,616 $ 222,442 $ 204,298 $ 207,447 $ 201,429 $ 732,687 Operating expenses: Educational services and facilities 118,334 117,429 110,448 420,491 112,258 105,604 102,488 100,141 384,529 Selling, general and administrative 97,328 103,634 94,709 331,656 85,198 84,542 88,106 73,810 289,267 Total operating expenses 215,662 221,063 205,157 752,147 197,456 190,146 190,594 173,951 673,796 Income from operations 3,245 339 15,687 83,469 24,986 14,152 16,853 27,478 58,891 Total other (expense) income, net (146) 44 525 805 573 200 (19) 51 (2,661) Income tax (expense) benefit (820) 50 (3,385) (21,256) (6,803) (3,689) (5,388) (5,376) (14,229) Net Income 2,279 433 12,827 63,018 18,756 10,663 11,446 22,153 42,001 Preferred stock dividends — — — — — — — — (1,097) Income available for distribution 2,279 433 12,827 63,018 18,756 10,663 11,446 22,153 40,904 Income allocated to participating securities — — — — — — — — (2,855) Net income available to common shareholders $ 2,279 $ 433 $ 12,827 $ 63,018 $ 18,756 $ 10,663 $ 11,446 $ 22,153 $ 38,049 Net income per share, diluted $ 0.04 $ 0.01 $ 0.23 $ 1.13 $ 0.34 $ 0.19 $ 0.21 $ 0.40 $ 0.75 EBITDA(1) $ 13,758 $ 9,361 $ 24,542 $ 116,692 $ 33,634 $ 22,616 $ 25,000 $ 35,442 $ 88,711 Total Shares Outstanding (Period End) 55,095 55,061 55,014 54,430 54,430 54,424 54,406 54,366 53,817 Weighted Average Diluted Shares Outstanding 55,935 55,730 55,744 55,615 55,728 55,635 55,442 55,406 50,851 1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18.

6 3 Mos. 3 Mos. 3 Mos. 12 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 12 Mos. 6/30/26 3/31/26 12/31/25 9/30/25 9/30/25 6/30/25 3/31/25 12/31/24 9/30/24 Revenues 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% Operating Expenses: Educational services and facilities 54.1% 53.0% 50.0% 50.3% 50.5% 51.7% 49.4% 49.8% 52.5% Selling, general and administrative 44.5% 46.8% 42.9% 39.7% 38.3% 41.4% 42.5% 36.6% 39.5% Total operating expenses 98.6% 99.8% 92.9% 90.0% 88.8% 93.1% 91.9% 86.4% 92.0% Income from operations 1.5% 0.2% 7.1% 10.0% 11.2% 6.9% 8.1% 13.6% 8.0% Total other (expense) income, net (0.2)% 0.0% 0.2% 0.1% 0.3% 0.1% 0.0% 0.1% (0.4)% Income tax (expense) benefit (0.4)% 0.0% (1.5)% (2.5)% (3.1)% (1.8)% (2.6)% (2.7)% (1.9)% Net Income 1.0% 0.2% 5.8% 7.6% 8.4% 5.2% 5.5% 11.0% 5.7% Preferred stock dividends —% —% —% —% —% —% —% —% (0.1)% Income available for distribution 1.0% 0.2% 5.8% 7.6% 8.4% 5.2% 5.5% 11.0% 5.6% Income allocated to participating securities —% —% —% —% —% —% —% —% (0.4)% Net income available to common shareholders 1.0% 0.2% 5.8% 7.6% 8.4% 5.2% 5.5% 11.0% 5.2% EBITDA(1) 6.3% 4.2% 11.1% 14.0% 15.1% 11.1% 12.1% 17.6% 12.1% Consolidated Results of Operations Trend Percent of Revenue 1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18.

7 Quarterly Trend – Segment Key Metrics ($ in millions, except revenue per student amounts) 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 6/30/26 3/31/26 12/31/25 9/30/25 6/30/25 6/30/26 3/31/26 12/31/25 9/30/25 6/30/25 UTI UTI UTI UTI UTI Concorde Concorde Concorde Concorde Concorde New student starts 3,491 4,110 2,893 7,166 2,829 2,851 3,459 2,556 4,943 2,892 Y/Y growth/(decline) 23.4% 14.5% 5.1% 1.4% (3.0)% (1.4)% 13.1% (0.2)% 11.7% 9.1% Average full-time active students 14,767 15,556 16,347 15,207 14,205 10,364 10,829 10,511 9,842 9,552 Y/Y growth/(decline) 4.0% 5.3% 5.7% 8.1% 8.9% 8.5% 10.2% 9.5% 8.0% 18.8% Revenue per student $9,300 $9,200 $8,700 $9,500 $9,300 $7,800 $7,300 $7,400 $7,900 $7,600 Y/Y growth/(decline) 0.0% 1.1% 2.4% 2.2% 3.3% 2.6% (1.4)% 1.4% 9.7% 1.3% Revenues $138.0 $142.7 $142.8 $144.6 $131.5 $80.9 $78.7 $78.0 $77.8 $72.8 Y/Y growth/(decline) 4.9% 6.3% 8.6% 10.8% 12.3% 11.1% 7.5% 11.4% 18.2% 20.7% Income (loss) from operations $5.8 $4.2 $15.9 $24.2 $17.7 $3.2 $(0.2) $3.8 $5.0 $1.1 Margin 4.2% 2.9% 11.1% 16.7% 13.5% 4.0% (0.3)% 4.9% 6.4% 1.5% Adjusted EBITDA(1) $14.3 $11.3 $22.7 $30.9 $24.3 $6.4 $2.2 $6.2 $7.3 $3.3 Adjusted EBITDA margin 10.3% 7.9% 15.9% 21.4% 18.4% 7.9% 2.7% 7.9% 9.4% 4.5% 1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18.

8 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 6/30/26 6/30/26 6/30/26 6/30/26 6/30/25 6/30/25 6/30/25 6/30/25 UTI Concorde Corporate Consolidated UTI Concorde Corporate Consolidated Revenues $ 138,015 $ 80,892 $ — $ 218,907 $ 131,462 $ 72,836 $ — $ 204,298 Compensation and benefits 58,274 36,699 19,898 114,871 51,230 34,122 17,423 102,775 Advertising 16,243 9,696 208 26,147 15,008 7,534 153 22,695 Occupancy 10,882 6,655 976 18,513 9,920 6,494 233 16,647 Student related 12,326 5,494 — 17,820 7,671 6,122 — 13,793 General operations 6,157 4,605 5,634 16,396 5,532 5,123 3,146 13,801 Depreciation and amortization 7,284 2,751 375 10,410 6,048 1,939 328 8,315 Professional and contract services 2,318 1,297 4,258 7,873 2,360 1,264 4,590 8,214 Other expenses 1,969 711 952 3,632 1,648 1,182 1,076 3,906 Corporate support 16,748 9,813 (26,561) — 14,320 7,933 (22,253) — Total operating expenses $ 132,201 $ 77,721 $ 5,740 $ 215,662 $ 113,737 $ 71,713 $ 4,696 $ 190,146 Income (loss) from operations $ 5,814 $ 3,171 $ (5,740) $ 3,245 $ 17,725 $ 1,123 $ (4,696) $ 14,152 Net income (loss) $ 5,020 $ 3,130 $ (5,871) $ 2,279 $ 16,439 $ 1,084 $ (6,860) $ 10,663 EBITDA(1) $ 13,097 $ 5,922 $ (5,261) $ 13,758 $ 23,775 $ 3,062 $ (4,221) $ 22,616 Adjusted EBITDA(1) $ 14,284 $ 6,400 $ (2,439) $ 18,245 $ 24,239 $ 3,270 $ (2,235) $ 25,274 Adjusted EBITDA margin 10.3% 7.9% —% 8.3% 18.4% 4.5% —% 12.4% 1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18. Segment Results of Operations: Third Quarter ($ in thousands)

9 9 Mos. 9 Mos. 9 Mos. 9 Mos. 9 Mos. 9 Mos. 9 Mos. 9 Mos. 6/30/26 6/30/26 6/30/26 6/30/26 6/30/25 6/30/25 6/30/25 6/30/25 UTI Concorde Corporate Consolidated UTI Concorde Corporate Consolidated Revenues $ 423,577 $ 237,576 $ — $ 661,153 $ 397,168 $ 216,006 $ — $ 613,174 Compensation and benefits 169,703 109,649 58,410 337,762 153,120 98,130 49,575 300,825 Advertising 53,213 28,988 607 82,808 44,536 22,791 551 67,878 Occupancy 32,035 19,255 2,866 54,156 28,245 18,206 674 47,125 Student related 34,648 16,588 — 51,236 26,511 17,010 — 43,521 General operations 21,818 13,534 16,283 51,635 14,479 12,985 8,322 35,786 Depreciation and amortization 20,326 6,991 1,044 28,361 17,947 5,499 1,006 24,452 Professional and contract services 7,516 3,857 13,212 24,585 7,330 3,868 13,457 24,655 Other expenses 5,862 2,345 3,132 11,339 4,860 2,777 2,812 10,449 Corporate support 52,611 29,608 (82,219) — 42,153 23,035 (65,188) — Total operating expenses $ 397,732 $ 230,815 $ 13,335 $ 641,882 $ 339,181 $ 204,301 $ 11,209 $ 554,691 Income (loss) from operations $ 25,845 $ 6,761 $ (13,335) $ 19,271 $ 57,987 $ 11,705 $ (11,209) $ 58,483 Net income (loss) $ 23,420 $ 6,683 $ (14,564) $ 15,539 $ 54,315 $ 11,591 $ (21,644) $ 44,262 EBITDA(1) $ 46,172 $ 13,753 $ (12,263) $ 47,662 $ 75,944 $ 17,204 $ (10,090) $ 83,058 Adjusted EBITDA(1) $ 48,338 $ 14,730 $ (3,528) $ 59,540 $ 77,357 $ 17,680 $ (5,361) $ 89,676 Adjusted EBITDA margin 11.4% 6.2% —% 9.0% 19.5% 8.2% —% 14.6% 1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18. Segment Results of Operations: Year-to-Date ($ in thousands)

10 Consolidated Balance Sheet and Cash Flow Summary ($ in thousands) At: 6/30/26 9/30/25 Cash & cash equivalents $ 130,060 $ 127,361 Short-term investments 40,060 41,784 Total current assets 258,081 246,632 PP&E (net) 338,764 285,852 Right-of-use assets for operating leases 182,004 178,861 Goodwill and intangible assets 53,994 45,811 Notes receivable, less current portion 45,439 41,109 Total assets 897,862 826,139 Operating lease liability, current portion 14,814 16,967 Long term debt, current portion 2,993 2,865 Total current liabilities 198,294 229,671 Operating lease liability 184,623 174,838 Long-term debt 157,041 84,234 Total liabilities 553,556 498,029 Stockholders’ equity 344,306 328,110 Total liabilities & equity $ 897,862 $ 826,139 9 Mos. 6/30/26 9 Mos. 6/30/25 Net cash provided by operating activities $ 17,402 $ 40,226 Purchase of property and equipment (80,900) (25,499) Capitalized costs for intangible assets (4,496) — Purchase of investments (57,347) (54,648) Proceeds from sale of investments 31,668 — Proceeds received upon maturity of investments 31,300 1,874 Proceeds from insurance policy 37 — Net cash used in investing activities (79,738) (78,273) Proceeds from revolving credit facility 195,000 6,000 Payments on revolving credit facility (120,000) (56,000) Payment of term loans and finance leases (2,133) (2,010) Proceeds from stock option exercises — 659 Payment of payroll taxes on stock-based compensation through shares withheld (8,730) (4,675) Net cash provided by (used in) financing activities 64,137 (56,026) Change in cash and restricted cash 1,801 (94,073) Ending balance of cash and restricted cash $ 135,931 $ 73,399

11 Earnings Per Share Trend and Guidance ($ in thousands, except EPS) Guidance Actual Actual Actual Actual Actual Actual Actual Actual Fiscal 2026 Midpoint 3 Mos. 6/30/26 3 Mos. 3/31/26 3 Mos. 12/31/25 12 Mos. 9/30/25 3 Mos. 9/30/25 3 Mos. 6/30/25 3 Mos. 3/31/25 3 Mos. 12/31/24 Net Income ~$32,000-36,000 $ 2,279 $ 433 $ 12,827 $ 63,018 $ 18,756 $ 10,663 $ 11,446 $ 22,153 Weighted average basic shares outstanding ~55,000 55,075 55,033 54,570 54,301 54,425 54,412 54,383 53,987 Basic income per common share ~$0.58-0.65 $ 0.04 $ 0.01 $ 0.24 $ 1.16 $ 0.34 $ 0.20 $ 0.21 $ 0.41 Weighted average basic shares outstanding ~55,000 55,075 55,033 54,570 54,301 54,425 54,412 54,383 53,987 Dilutive effect related to employee stock plans ~1,300 860 697 1,175 1,314 1,303 1,223 1,059 1,419 Weighted average diluted shares outstanding ~56,300 55,935 55,730 55,745 55,615 55,728 55,635 55,442 55,406 Diluted income per common share ~$0.57-0.64 $ 0.04 $ 0.01 $ 0.23 $ 1.13 $ 0.34 $ 0.19 $ 0.21 $ 0.40

12 Leverage Ratios Leverage as of 6/30/2026 Current Loan Balances $160.0M LTM EBITDA $96.2M Cash, Cash Equivalents, and Short-Term Investments $170.1M Gross Leverage Ratio 1.66x Net Leverage Ratio (0.10)x Proforma Leverage 9/30/2026 Note Balances, net (Projected) ~$95M LTM EBITDA - FY 2026 Guidance Midpoint ~$101.5M Cash, Cash Equivalents, and Short-Term Investments (Projected) ~$145.0M Gross Leverage Ratio ~0.95x Net Leverage Ratio ~(0.47)x 9/30/2026 proforma leverage calculation is based upon midpoint of the adjusted EBITDA guidance range and projected year-end cash balance, both of which will depend on actual company performance. For a detailed reconciliation of Non-GAAP measures, see slides 14-18. Note: Use of the revolver will continue to be evaluated throughout the year and used as needed to satisfy regulatory requirements &/or debt covenants. Any change to the outstanding revolver balance would affect gross leverage but have no impact on net leverage. Debt as of 6/30/2026 Term Loan: Avondale Campus Original Note Amount $31.2M Inception Date 5/12/2021 Rate* Fixed/Floating Maturity 7 years Current Note Balance $26.8M Term Loan: Lisle Campus Original Note Amount $38.0M Inception Date 4/14/2022 Rate** Fixed/Floating Maturity 7 years Current Note Balance $35.4M Revolving Credit Facility Total Capacity $125.0M Inception Date 11/21/2022 Rate*** Floating Maturity 5 years Current Loan Balance $95.0M *Avondale rate is 50% fixed at 1.45% + 50% Floating @ SOFR plus 2% Margin and a tranche adjustment of 0.046% **Lisle rate is 50% fixed at 4.69% + 50% Floating @ SOFR plus 2% Margin ***Revolver rate is SOFR plus 1.75% to 2.25% Margin based on UTI's Total Leverage

13 In addition to disclosing financial results that are determined in accordance with U.S. generally accepted accounting principles ("GAAP"), the Company also discloses certain non-GAAP financial information in this press release and may similarly disclose non-GAAP financial information on the related conference call. These financial measures are not recognized measures under GAAP and are not intended to be and should not be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. The Company discloses these non-GAAP financial measures because it believes that they provide investors an additional analytical tool to clarify its results of operations and identify underlying trends. Additionally, the Company believes that these measures may also help investors compare its performance on a consistent basis across time periods. Additional details on our non-GAAP measures and the tables reconciling these measures to the most directly comparable GAAP measure are provided below. Management utilizes adjusted figures as performance measures internally for operating decisions, strategic planning, annual budgeting and forecasting. For the periods presented, our adjustments for items that management does not consider to be normal recurring operations include: • Acquisition-related costs: We have excluded costs associated with both potential and announced acquisitions to allow for comparable financial results to historical operations and forward-looking guidance. • Integration-related costs for completed acquisitions: We have excluded integration costs related to business structure realignment and new programs for recent acquisitions to allow for comparable financial results to historical operations and forward-looking guidance. In addition, the nature and amount of such charges vary significantly based on the size and timing of the programs. By excluding the referenced expenses from our non-GAAP financial measures, our management is able to further evaluate our ability to utilize existing assets and estimate their long-term value. Furthermore, our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance. • Restructuring costs: In May 2026, management approved and implemented phase I of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. Additional phases of this restructuring plan will be rolled out over the next three years as part of our continued focus on optimization and to better align resources to support our overall growth strategy. In December 2023, we announced plans to consolidate the two Houston, Texas campus locations to align the curriculum, student facing systems, and support services to better serve students seeking careers in in-demand fields. As part of the transition, the MIAT Houston campus, acquired in November 2021, began a phased teach-out in May 2024, and such campus began operating under the UTI brand. To obtain a complete understanding of our performance, these measures should be examined in connection with net income (loss) and net cash provided by (used in) operating activities, determined in accordance with GAAP, as presented in the financial statements and notes thereto included in the annual and quarterly filings with the Securities and Exchange Commission (“SEC”). Because the items excluded from these non-GAAP measures are significant components in understanding and assessing our financial performance under GAAP, these measures should not be considered to be an alternative to net income (loss) or net cash provided by (used in) operating activities as a measure of our operating performance or liquidity. Exclusion of items in the non-GAAP presentation should not be construed as an inference that these items are unusual, infrequent or non-recurring. Other companies, including other companies in the education industry, may define and calculate non-GAAP financial measures differently than we do, limiting their usefulness as a comparative measure across similarly titled performance measures presented by other companies. A reconciliation of the historical non-GAAP financial measures to the most directly comparable GAAP measures is provided below and investors are encouraged to review the reconciliations. Information reconciling forward-looking adjusted EBITDA and adjusted free cash flow to the most directly comparable GAAP financial measure is unavailable to the company without unreasonable effort. The company is not able to provide a quantitative reconciliation of forward-looking adjusted EBITDA or adjusted free cash flow to the most directly comparable GAAP financial measure because certain items required for such reconciliation are uncertain, outside of the company’s control and/or cannot be reasonably predicted, including but not limited to the provision for (benefit from) income taxes. Preparation of such reconciliation would require a forward-looking statement of income and statement of cash flows prepared in accordance with GAAP, and such forward-looking financial statements are unavailable to the company without unreasonable effort. Use of Non-GAAP Financial Information

14 QUARTER-TO-DATE 3 Mos. 6/30/26 3 Mos. 3/31/26 3 Mos. 12/31/25 12 Mos. 9/30/25 3 Mos. 9/30/25 3 Mos. 6/30/25 3 Mos. 3/31/25 3 Mos. 12/31/24 12 Mos. 9/30/24 Net income, as reported $ 2,279 $ 433 $ 12,827 $ 63,018 $ 18,756 $ 10,663 $ 11,446 $ 22,153 $ 42,001 Interest (income) expense, net 249 (67) (575) (540) (431) (51) 28 (86) 3,157 Income tax (benefit) expense 820 (50) 3,385 21,256 6,803 3,689 5,388 5,376 14,229 Depreciation and amortization 10,410 9,045 8,905 32,958 8,506 8,315 8,138 7,999 29,324 EBITDA $ 13,758 $ 9,361 $ 24,542 $ 116,692 $ 33,634 $ 22,616 $ 25,000 $ 35,442 $ 88,711 Stock-based compensation expense 2,970 3,901 2,555 9,151 2,749 2,658 3,024 720 8,560 Integration related costs for completed acquisitions(1) 421 884 51 (304) 396 — — (700) 6,049 Restructuring costs(2) 1,096 — — 43 — — — 43 185 Acquisition related costs(3) — — — 873 — — 873 — — Facility lease accounting adjustments(4) — — — — — — — — (650) Adjusted EBITDA, non-GAAP $ 18,245 $ 14,146 $ 27,148 $ 126,455 $ 36,779 $ 25,274 $ 28,897 $ 35,505 $ 102,855 Consolidated Adjusted EBITDA Reconciliation ($ in thousands) 1. In fiscal 2025, the Company received $0.7 million in funds in final settlement of the outstanding escrow accounts affiliated with the purchase of Concorde on December 1, 2022. This is offset by additional integration costs incurred during the year. 2. In May 2026, management approved and implemented phase I of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025. 3. Costs related to both announced and potential acquisition targets. 4. Lease accounting adjustment for a lease termination payment for the previous Concorde corporate offices.

15 YEAR-TO-DATE 9 Mos. 6/30/26 6 Mos. 3/31/26 3 Mos. 12/31/25 12 Mos. 9/30/25 9 Mos. 6/30/25 6 Mos. 3/31/25 3 Mos. 12/31/24 12 Mos. 9/30/24 Net income, as reported $ 15,539 $ 13,260 $ 12,827 $ 63,018 $ 44,262 $ 33,599 $ 22,153 $ 42,001 Interest (income) expense, net (393) (642) (575) (540) (109) (58) (86) 3,157 Income tax expense 4,155 3,335 3,385 21,256 14,453 10,764 5,376 14,229 Depreciation and amortization 28,361 17,950 8,905 32,958 24,452 16,137 7,999 29,324 EBITDA $ 47,662 $ 33,903 $ 24,542 $ 116,692 $ 83,058 $ 60,442 $ 35,442 $ 88,711 Stock-based compensation expense 9,426 6,456 2,555 9,151 6,402 3,744 720 8,560 Integration related costs for completed acquisitions(1) 1,356 935 51 (304) (700) (700) (700) 6,049 Restructuring costs(2) 1,096 — — 43 43 43 43 185 Acquisition related costs(3) — — — 873 873 873 — — Facility lease accounting adjustments(4) — — — — — — — (650) Adjusted EBITDA, non-GAAP $ 59,540 $ 41,294 $ 27,148 $ 126,455 $ 89,676 $ 64,402 $ 35,505 $ 102,855 Consolidated Adjusted EBITDA Reconciliation ($ in thousands) 1. In fiscal 2025, the Company received $0.7 million in funds in final settlement of the outstanding escrow accounts affiliated with the purchase of Concorde on December 1, 2022. This is offset by additional integration costs incurred during the year. 2. In May 2026, management approved and implemented phase I of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025. 3. Costs related to both announced and potential acquisition targets. 4. Lease accounting adjustment for a lease termination payment for the previous Concorde corporate offices.

16 Adjusted EBITDA Reconciliation By Segment ($ in thousands) QUARTER-TO-DATE 3 Mos. 6/30/26 3 Mos. 6/30/25 3 Mos. 6/30/26 3 Mos. 6/30/25 3 Mos. 6/30/26 3 Mos. 6/30/25 UTI UTI Concorde Concorde Corporate Corporate Net income (loss), as reported $ 5,020 $ 16,439 $ 3,130 $ 1,084 $ (5,871) $ (6,860) Interest expense (income), net 793 1,288 41 39 (585) (1,378) Income tax (benefit) expense — — — — 820 3,689 Depreciation and amortization 7,284 6,048 2,751 1,939 375 328 EBITDA $ 13,097 $ 23,775 $ 5,922 $ 3,062 $ (5,261) $ (4,221) Stock-based compensation expense 475 464 248 208 2,247 1,986 Integration related costs for completed acquisitions — — — — 421 — Restructuring costs(1) 712 — 230 — 154 — Adjusted EBITDA, non-GAAP $ 14,284 $ 24,239 $ 6,400 $ 3,270 $ (2,439) $ (2,235) 1. In May 2026, management approved and implemented phase I of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025.

17 Adjusted EBITDA Reconciliation By Segment ($ in thousands) YEAR-TO-DATE 9 Mos. 6/30/26 9 Mos. 6/30/25 9 Mos. 6/30/26 9 Mos. 6/30/25 9 Mos. 6/30/26 9 Mos. 6/30/25 UTI UTI Concorde Concorde Corporate Corporate Net income (loss), as reported $ 23,420 $ 54,315 $ 6,683 $ 11,591 $ (14,564) $ (21,644) Interest expense (income), net 2,426 3,682 79 114 (2,898) (3,905) Income tax expense — — — — 4,155 14,453 Depreciation and amortization 20,326 17,947 6,991 5,499 1,044 1,006 EBITDA $ 46,172 $ 75,944 $ 13,753 $ 17,204 $ (12,263) $ (10,090) Stock-based compensation expense 1,454 1,370 747 476 7,225 4,556 Integration related costs for completed acquisitions(1) — — — — 1,356 (700) Restructuring costs(2) 712 43 230 — 154 — Acquisition related costs(3) — — — — — 873 Adjusted EBITDA, non-GAAP $ 48,338 $ 77,357 $ 14,730 $ 17,680 $ (3,528) $ (5,361) 1. In fiscal 2025, the Company received $0.7 million in funds in final settlement of the outstanding escrow accounts affiliated with the purchase of Concorde on December 1, 2022. This is offset by additional integration costs incurred during the year. 2. In May 2026, management approved and implemented phase I of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025. 3. Costs related to both announced and potential acquisition targets.

18 3 Mos. 6/30/26 3 Mos. 6/30/25 9 Mos. 6/30/26 9 Mos. 6/30/25 Cash flow provided by operating activities, as reported $10,333 $18,053 $17,402 $40,226 Purchase of property and equipment (28,239) (11,207) (80,900) (25,499) Capitalized costs for intangible assets (3,243) — (4,496) — Free cash flow, non-GAAP $(21,149) $6,846 $(67,994) $14,727 Adjustments: Cash outflow (inflow) for integration-related costs for completed acquisitions(1) 546 — 1,986 (700) Cash outflow for acquisition-related costs(2) — 112 — 873 Cash outflow for restructuring costs(3) 411 4 411 59 Adjusted free cash flow, non-GAAP $(20,192) $6,962 $(65,597) $14,959 1. In fiscal 2025, the Company received $0.7 million in funds in final settlement of the outstanding escrow accounts affiliated with the purchase of Concorde on December 1, 2022. This is offset by additional integration costs incurred during the year. 2. Costs related to both announced and potential acquisition targets. 3. In May 2026, management approved and implemented phase I of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025. Consolidated Adjusted Free Cash Flow ($ in thousands)

THANK YOU